A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation

Cancer Letters
Gang XueBurong Hu

Abstract

It is believed that epigenetic modification plays roles in cancer initiation and progression. Both microRNA and DNA methyltransferase are epigenetic regulation factors. It was found that miR-145 upregulates while DNMT3b downregulates in PC3 cells. Presence of any negative correlationship and their response to irradiation were investigated in the current study. We found that miR-145 downregulated DNMT3b expression by directly targeting the 3'-UTR of DNMT3b mRNA and knockdown of DNMT3b increased expression of miR-145 via CpG island promoter hypomethylation, suggesting that there is a crucial crosstalk between miR-145 and DNMT3b via a double-negative feedback loop. Responses of the miR-145 and DNMT3b to irradiation are a negative correlation. We also found that either overexpression of miR-145 or knockdown of DNMT3b sensitized prostate cancer cells to X-ray radiation. Our findings enrich the complex relationships between miRNA and DNMTs in carcinogenesis and irradiation stress. It also sheds light on the potential combination of ionizing radiation and epigenetic regulation in prostate cancer therapy.

References

Sep 27, 2000·Human Molecular Genetics·T H Bestor
May 17, 2002·The Journal of Biological Chemistry·Normand BeaulieuA Robert MacLeod
Jul 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yoshimasa SaitoSetsuo Hirohashi
Aug 17, 2005·Cancer Research·Marilena V IorioCarlo M Croce
Dec 22, 2006·Nature Reviews. Molecular Cell Biology·Tariq M Rana
Jul 10, 2007·Cancer Research·Kati P PorkkaTapio Visakorpi
Sep 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Muller FabbriCarlo M Croce
Feb 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mohit SachdevaYin-Yuan Mo
Apr 11, 2009·International Journal of Oncology·Shihua WangRobert Chunhua Zhao
Apr 21, 2009·International Journal of Cancer. Journal International Du Cancer·Takahiro IchimiNaohiko Seki
Jun 19, 2009·RNA Biology·Fabio Petrocca, Judy Lieberman
Dec 10, 2009·Cancer Research·Mohit Sachdeva, Yin-Yuan Mo
Mar 2, 2010·Cell Cycle·Fadila GuessousRoger Abounader
May 8, 2010·Epigenetics : Official Journal of the DNA Methylation Society·Sole GattoMaria R Matarazzo
Oct 15, 2010·Cancer·Filipe Ivan DanielFernanda Gonçalves Salum
Nov 26, 2010·Journal of Experimental & Clinical Cancer Research : CR·Zhe ChenJian Hu
May 13, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Kwoneel KimYong Sung Kim
Aug 6, 2011·International Journal of Radiation Biology·Ashok KumarKapettu Satyamoorthy
Jun 19, 2012·Clinical Epigenetics·Suyin P ChinAdele F Holloway
Mar 14, 2013·The FEBS Journal·Martin HartBernd Wullich
Jun 14, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Diamantina VasilatouVasiliki Pappa
Jul 25, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Deborah A AntwihSteven P Zielske
Sep 3, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hailin TangXiaoming Xie
Jan 5, 2014·Journal of Cancer Research and Clinical Oncology·Ruijing LuZhendong Yu
May 2, 2014·Endocrine-related Cancer·Myriem BoufraqechElectron Kebebew
Jun 30, 2014·International Journal of Radiation Oncology, Biology, Physics·Bo WangOlga Kovalchuk

❮ Previous
Next ❯

Citations

Jan 30, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Balraj Singh GillSanjeev Kumar
Aug 28, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hongzhi LuYing Su
Jan 7, 2017·Epigenetics : Official Journal of the DNA Methylation Society·Sumei WangFrancois X Claret
Mar 27, 2018·The Journal of Gene Medicine·Olga E BryzgunovaPavel P Laktionov
Oct 21, 2017·Bioscience, Biotechnology, and Biochemistry·Jin YangXiao Gu
Aug 18, 2020·Cancer Management and Research·Xin YangAlimu Reheman
Jan 4, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Liangliang XuMingqing Xu
Feb 4, 2021·Environmental Science and Pollution Research International·Yonglin ChenLan Yi
Nov 6, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tahereh ZeinaliBehzad Baradaran
Feb 12, 2019·Seminars in Cancer Biology·Ammad Ahmad FarooqiGeorge A Calin
Oct 15, 2020·Andrology·Maria Yu KonoshenkoPavel P Laktionov
Mar 9, 2021·Frontiers in Cell and Developmental Biology·Qin PengYongzhong Wu
Mar 21, 2021·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ariana Cabrera-LiconaElena Aréchaga-Ocampo
Apr 23, 2021·Cancer Biotherapy & Radiopharmaceuticals·Weihe ZhouYi Jiang
Aug 21, 2021·Frontiers in Oncology·Sílvia SoaresRúben Fernandes
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Longqiu YangXuejie Fei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.